Icahn School of Medicine at Mount Sinai Reports Findings in Psoriasis (Deep Resolution of Clinical, Cellular and Transcriptomic Inflammatory Markers of Psoriasis Over 52 Weeks of Interleukin-17a Inhibition By Secukinumab)

Press/Media

Period5 Jun 2024

Media coverage

1

Media coverage

  • TitleIcahn School of Medicine at Mount Sinai Reports Findings in Psoriasis (Deep Resolution of Clinical, Cellular and Transcriptomic Inflammatory Markers of Psoriasis Over 52 Weeks of Interleukin-17a Inhibition By Secukinumab)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date5/06/24
    PersonsMayte Suarez-Farinas